Nicorette Invisipatch (Nicotine)

Nicotine, the active ingredient in Nicorette Invisipatch, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adult smokers who wish to quit by delivering a controlled amount of nicotine through the skin, thereby reducing withdrawal symptoms and cravings associated with tobacco dependence.

GNH USA supplies Nicorette Invisipatch as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to EU quality standards and serving hospitals, pharmacies and clinics worldwide. The company provides reliable logistics and regulatory support for cross‑border procurement.

Nicorette Invisipatch is a nicotine replacement therapy used in the management of tobacco dependence.

Smoking cessation: delivers steady nicotine to lessen cravings and withdrawal, supporting adults who are trying to quit smoking.

Nicotine patches can cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Skin irritation at the application site - Sleep disturbance (insomnia) - Nausea - Headache - Dizziness - Increased salivation

Serious or Rare Side Effects: - Allergic reaction (rash, swelling) - Severe skin necrosis - Chest pain - Rapid heart rate (tachycardia) - Hypertension - Mood changes (depression, anxiety)

When using Nicorette Invisipatch, several precautions should be observed to ensure safe and effective therapy.

- Assess suitability: confirm patient is an adult smoker motivated to quit. - Avoid use in patients with recent heart attack or uncontrolled hypertension. - Do not apply to broken or irritated skin. - Rotate application sites to minimize skin irritation. - Remove patch before exposure to high heat (e.g., heating pads, saunas). - Store at room temperature: keep in original pouch, protect from moisture and direct sunlight.

Nicotine delivered via the Invisipatch may interact with other medicines, altering their effects or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis. - Certain antidepressants (e.g., bupropion): heightened cardiovascular side effects.

Moderate Interactions (Monitor Closely): - Caffeine‑containing products: may increase jitteriness. - Beta‑blockers: nicotine can reduce their blood‑pressure‑lowering effect. - Antidiabetic drugs: nicotine may affect glucose control. - Hormonal contraceptives: nicotine can reduce efficacy.